I agree with both you and
@fluffynymph.
As much as I copped flack during that long suspension as people struggled with understanding the process, I do know that I spent an inordinate amount of time doing my best to keep shareholders and interested parties up to date and making the Quarterlies as detailed as possible.
Reputation certainly has a lot to do with trust and how much investors are willing to "trust" their hard-earned with a company.
I know their products work. I have medical proof of improvements in my body. I know the quality is also as good as you will get, having tried many different brands of hemp over the years.
Fluffy, I agree with you and
@jcurve on the book value; heavily discounted, IMO. I know the fundamentals are solid on paper, discounting revenues (Penny). I also know, with some confidence and from my own research, the difficulties facing the industry in which this company currently operates in. I also believe that people are finally realising this too.
I look at the T.V.S., looking at analyst's reports from Thomsons Reuters, NAB and others. I see CGB towards the top group on what the market estimates and predicts; what the company could achieve based on financials; global pressures, and current market/sector conditions.
Talking with a CGB investor friend of mine recently, the bottom line is this:
If a football team fails, they must look at the coach and the mgmt team. It is also why I believe I have observed BOTS playing with the share price like it was a chew toy over the past 10 days.
I believe I know what has to be done and as a shareholder, I am doing it.
Just an opinion, you are welcome to agree or disagree.
